ArticleJCI insight2026

A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model.

Enming J Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.